Jump to: navigation, search
Monoclonal antibody
SourceTemplate:Infobox drug/mab source
TargetCD3 receptor
E number{{#property:P628}}
ECHA InfoCard{{#property:P2566}}Lua error in Module:EditAtWikidata at line 36: attempt to index field 'wikibase' (a nil value).

Visilizumab (marketed under the trade name Nuvion by PDL BioPharma Inc.) is a humanized monoclonal antibody. It is being investigated for use as an immunosuppressive drug in patients with ulcerative colitis and Crohn disease. Visilizumab binds to the CD3 receptor on certain activated T cells without effecting resting T cells.

External link